Investigation of cell signalings and therapeutic targets in PTPRK-RSPO3 fusion-positive colorectal cancer

INTRODUCTION: Colorectal cancer (CRC) is one of the most deadly and common diseases in the world, accounting for over 881,000 casualties in 2018. The PTPRK-RSPO3 (P:R) fusion is a structural variation in CRC and well known for its ability to activate WNT signaling and tumorigenesis. However, till no...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Jae Heon, Yun, Jae Won, Kim, Ha Young, Heo, Chan Yeong, Lee, Sejoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491571/
https://www.ncbi.nlm.nih.gov/pubmed/36129915
http://dx.doi.org/10.1371/journal.pone.0274555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491571/
https://www.ncbi.nlm.nih.gov/pubmed/36129915
http://dx.doi.org/10.1371/journal.pone.0274555

Ejemplares similares